Yannick Aimé Eddy Ligny

Title: Yannick Aimé Eddy Ligny: Innovator in Pharmaceutical Chemistry

Introduction

Yannick Aimé Eddy Ligny is a notable inventor based in Sotteville-lès-Rouen, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit farnesyl transferase. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Yannick Ligny holds 2 patents that focus on intermediate compounds in the preparation of farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives. These patents include:

1. Intermediate compounds in the preparation of farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles.

2. Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles.

These inventions concern compounds of a specific formula that have potential therapeutic applications.

Career Highlights

Yannick Ligny is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions for complex medical challenges. His expertise in the field has been instrumental in advancing research and development efforts within the company.

Collaborations

Throughout his career, Yannick has collaborated with esteemed colleagues, including Marc Gaston Venet and Patrick René Angibaud. These collaborations have fostered a productive environment for innovation and have contributed to the success of their joint projects.

Conclusion

Yannick Aimé Eddy Ligny is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that inhibit farnesyl transferase. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the field positively.